CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
26 hedge funds and large institutions have $1.95M invested in Carisma Therapeutics in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
63% less capital invested
Capital invested by funds: $5.26M → $1.95M (-$3.31M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $8K
Holders
26
Holding in Top 10
–
Calls
–
Puts
$8K
Top Buyers
| 1 | +$175K | |
| 2 | +$148K | |
| 3 | +$77K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$38.6K |
Top Sellers
| 1 | -$2.91M | |
| 2 | -$207K | |
| 3 | -$65K | |
| 4 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$58K |
| 5 |
Goldman Sachs
New York
|
-$35K |